ESCRS - PO102 - First European Comparatives Clinical Results For A Violet Light Filtering Trifocal Iol

First European Comparatives Clinical Results For A Violet Light Filtering Trifocal Iol

Published 2022 - 40th Congress of the ESCRS

Reference: PO102 | Type: Free paper | DOI: 10.82333/ksd6-ck29

Authors: Lena Beckers* 1 , Hakan Kaymak 2 , Karsten Klabe 2 , Mücella Kirca 3 , Florian Kretz 4 , Gerd Auffarth 5 , Detlev Breyer 2

1Breyer-Kaymak-Klabe Eye Surgery & premium Eyes,Düsseldorf,Germany, 2Breyer-Kaymak-Klabe Eye Surgery & premium Eyes,Düsseldorf,Germany;Internationale Innovative Ophthalmochirurgie,Düsseldorf,Germany;International Vision Correction Research Center Network (IVCRC.net),Heidelberg,Germany, 3Internationale Innovative Ophthalmochirurgie,Düsseldorf,Germany, 4Augentagesklinik Rheine,Rheine,Germany;International Vision Correction Research Center Network (IVCRC.net),Heidelberg,Germany, 5Augenklinik, Universitätsklinikum Heidelberg,Heidelberg,Germany;International Vision Correction Research Center Network (IVCRC.net),Heidelberg,Germany

Purpose

The goal was to compare a new trifocal MIOL with violet light filter with well-established trifocal MIOL (LISA, CZM und Panoptix, Alcon).

Setting

All surgeries were performed by one surgeon at the Breyer-Kaymak-Klabe Eye Surgery and Premium Eyes in Duesseldorf, Germany, member of the International Vision Correction Research Center (IVCRC.net).

 

Methods

20 eyes of 10 patients with cataract and expected postoperative corneal astigmatism of under -0.75D were included. In all eyes, a new hydrophobic diffractive refractive aspheric trifocal MIOL with violet light filter (Optiflex Trio; Biotech, India) was implanted. We assessed subjective refraction, monocular uncorrected and best distance corrected visual acuity for far, intermediate and near distances, and monocular defocus capacity after 3 months postoperatively. Halo and Glare phenomena were documented in a patient questionnaire.

Results

The defocus curve showed comparable far, intermediate and near vision to both well-established trifocal MIOL. Evaluation of the patient questionnaire also indicated similar halo & glare phenomena like in patients with both comparative trifocal MIOL.

Conclusions

The visual outcome of Optiflex Trio was comparable to both well-established trifocal MIOL. The defocus capacity of this violet light filtering trifocal MIOL is more like that of Panoptix. Optiflex Trio is an interesting alternative to LISA and Panoptix.